Page 19 - Astrazeneca

UK becomes world's first nation to approve AstraZeneca-Oxford Covid vaccine

The government has today accepted the recommendation to authorise Oxford University/AstraZeneca's Covid-19 vaccine for use, the health ministry said

AstraZeneca's Covid-19 vaccine not ready for quick EU nod: Regulator

Pakistan, Japan find cases with new coronavirus variants on their own soil

UK set to clear Astra shot; Novavax starts late-stage trial in US

Lockdowns in UK could ease in weeks with introduction of another vaccine

Nod for Covid vaccine in the next few days: Serum Institute's Poonawalla

SII has stockpiled 40-50 mn doses and is adding more every week. Most of these will come to India, as exporting would require fulfilling WHO's pre-qualification procedures

Oxford/AstraZeneca vaccine should be effective against new variant: Report

The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, the report said

We are researching two candidates for Covid vaccines: Serum Institute CEO

In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity

AstraZeneca submitted data for MHRA approval, says UK Health Minister

UK health secretary said that AstraZeneca had submitted a full data package about its Covid-19 vaccine to the Medicines and Healthcare products Regulatory Agency (MHRA) for approval

Sensex gains for 2nd day, ends 437 pts up at 46,444; HUL, Infy top gainers

India VIX cooled off over 6 per cent to end at 20.5 levels

India likely to approve AstraZeneca vaccine by next week: Sources

This could be the first country to give the regulatory green light for the British drugmaker's vaccine as the British medicine regulator continues to examine data from the trials

AstraZeneca's Fasenra gets regulatory nod for asthma treatment

AstraZeneca India has received marketing authorisation from the Drugs Controller General of India (DCGI) for use of Fasenra

Russia, AstraZeneca sign pact to test combination of Covid-19 shots

Developers of the Russian Covid-19 vaccine announced signing an agreement with AstraZeneca to test a combination of the British drugmaker's Covid shots and a component of the vaccine created in Moscow

AstraZeneca, Russia's Sputnik V developer to sign cooperation memorandum

President Vladimir Putin hailed British drugmaker AstraZeneca's decision to test combining its own experimental Covid-19 vaccine with Russia's Sputnik V shot

AstraZeneca Pharma gets nod from drug regulator to market asthma medicine

AstraZeneca Pharma said it has received marketing authorisation from Drug Controller General of India for Benralizumab solution, indicated as an add-on maintenance treatment for severe asthma

Serum Institute to seek nod for two full-dose regimen of Covishield

Suresh Jadhav, executive director of the Pune-based firm, said on Friday Serum was seeking approval from the Drug Controller General of India (DCGI) for the two-full dose regimen

COVAX gains access to 2 billion doses of vaccines for 190 member economies

First deliveries are expected to begin in the first quarter of 2021 depending upon regulatory approvals and readiness of countries for delivery

Despite heroic work for Covid vaccine, pharma cos don't deserve affection

A financial analyst recently told that Pfizer's involvement in the coronavirus pandemic was about "as much public relations as it is a financial return

States told to estimate and strengthen cold chain for vaccine: Health secy

In all, 29,000 cold chain points, 240 walk-in coolers, 70 walk-in freezers, 45,000 ice-lined refrigerators, 41,000 deep freezers and 300 solar refrigerators are to be used

Stuck in Sydney hotel, Astra CEO defended Covid vaccine and made mega deal

AstraZeneca announced Saturday it plans to buy rare-disease specialist Alexion Pharmaceuticals in a $39 billion deal

Covid-19 vaccines raise hope for cancer, throw open new field of medicine

Approach used by Moderna. and Pfizer, BioNTech SE partnership have never been used outside of clinical experiments.

AstraZeneca to buy Alexion for $39 billion to expand in immunology

AstraZeneca is one of the frontrunners in the drugs industry's search for a Covid-19 vaccine